<p>ICU 醫療（NASDAQ:ICUI - 獲取免費報告）在週三發佈給投資者的研究報告中，被 StockNews.com 從 “持有” 評級上調至 “買入” 評級。</p>
<p>其他一些分析師也對該公司發表了看法。傑富瑞金融集團在 10 月 14 日星期一發布的研究報告中開始覆蓋 ICU 醫療。他們對該股票給予了 “持有” 評級，並設定了 183.00 美元的目標價。KeyCorp 在 11 月 13 日的研究報告中將 ICU 醫療的目標價從 198.00 美元上調至 209.00 美元，並給予該公司 “增持” 評級。Needham &amp; Company LLC 在 11 月 13 日的報告中重新發布了對 ICU 醫療股票的 “持有” 評級。最後，Raymond James 在 9 月 12 日的研究報告中將 ICU 醫療的目標價從 158.00 美元上調至 190.00 美元，並給予該股票 “跑贏大盤” 評級。兩位分析師對該股票給予了持有評級，四位分析師則給予了買入評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，平均目標價為 173.00 美元。</p>
<p><strong>查看我們關於 ICUI 的最新報告</strong></p>
<h2>ICU 醫療股票表現</h2>
<p>NASDAQ:ICUI 在週三開盤價為 169.70 美元。該股票的 50 日移動平均線為 176.59 美元，200 日移動平均線為 144.30 美元。ICU 醫療的 52 周低點為 82.82 美元，52 周高點為 196.26 美元。該公司的市值為 41.5 億美元，市盈率為-37.13，貝塔值為 0.66。該公司的債務與股本比率為 0.75，速動比率為 1.03，流動比率為 2.29。</p>
<h2>內部買賣</h2>
<p>在相關消息中，首席執行官 Vivek Jain 在 10 月 1 日星期二出售了 12,000 股公司的股票。該股票以平均價格 178.46 美元出售，總價值為 2,141,520.00 美元。出售完成後，首席執行官現在直接持有 104,593 股公司的股票，價值為 18,665,666.78 美元。這代表其持股減少了 10.29%。該出售在向證券交易委員會提交的文件中披露，相關文件可通過 SEC 網站獲取。此外，副總裁 Daniel Woolson 在 8 月 30 日星期五出售了 2,502 股公司的股票。該股票以平均價格 163.22 美元出售，總價值為 408,376.44 美元。出售後，副總裁現在直接持有 13,107 股公司的股票，價值約為 2,139,324.54 美元。這代表其持股減少了 16.03%。該出售的披露信息可以在此找到。在過去三個月中，內部人士出售了 38,502 股公司股票，價值為 6,573,496 美元。6.70% 的股票由公司內部人士持有。</p>
<h2>對 ICU 醫療的對沖基金看法</h2>
<p>一些大型投資者最近調整了他們對 ICU 醫療的持股。SG Americas Securities LLC 在第二季度將其在 ICU 醫療的持股增加了 441.7%。SG Americas Securities LLC 現在持有 5,818 股醫療器械供應商的股票，價值為 691,000 美元，此前在上個季度又購買了 4,744 股。Sei Investments Co.在第一季度將其在 ICU 醫療的持股增加了 52.1%。Sei Investments Co.現在持有 28,586 股醫療器械供應商的股票，價值為 3,068,000 美元，此前在上個季度又購買了 9,793 股。Silvercrest 資產管理集團在第一季度將其在 ICU 醫療的持股增加了 109.4%。Silvercrest 資產管理集團現在持有 278,436 股醫療器械供應商的股票，價值為 29,882,000 美元，此前在上個季度又購買了 145,485 股。先鋒集團在第一季度將其在 ICU 醫療的持股增加了 0.5%。先鋒集團現在持有 2,452,720 股醫療器械供應商的股票，價值為 263,226,000 美元，此前在上個季度又購買了 11,991 股。最後，Savant Capital LLC 在第二季度收購了 ICU 醫療的新股份，價值為 431,000 美元。96.10% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>關於 ICU 醫療</h2>
<p>（獲取免費報告）</p>
<p>ICU 醫療公司及其子公司開發、製造和銷售用於輸液治療、血管通路和生命監護應用的醫療設備。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢設備；ChemoClave 和 ChemoLock 封閉系統轉移設備，用於限制有害藥物或蒸汽濃度的逸出，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 非穿刺針用於門靜脈通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 ICU 醫療</li>
<li>股息篩選器：如何在購買前評估股息股票</li>
<li>超級微型計算機飆升 28%：它真的走出困境了嗎？</li>
<li>股息之王寶潔在財報後疲軟時值得買入</li>
<li>交易者紛紛迴歸石油：是什麼推動了樂觀情緒</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>3 個熱門股票趨勢，助力 2025 年</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<p>→ 即使特朗普也無法阻止即將發生的事情。（來自市場背後）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ4NA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ4NA"/></p>
<h2>你現在應該投資 $1,000 在 ICU 醫療嗎？</h2>
<p>在考慮 ICU 醫療之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 ICU 醫療並不在名單上。</p>
<p>雖然 ICU 醫療目前在分析師中獲得了 “適度買入” 的評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ICU醫療

<p>ICU 醫療（NASDAQ:ICUI）被 StockNews.com 從 “持有” 評級上調至 “買入” 評級。其他分析師也給出了不同的評級，Jefferies Financial Group 維持 “持有” 評級，而 KeyCorp 和 Raymond James 則提高了他們的目標價格，並分別給予 “增持” 和 “跑贏大盤” 評級。該股票目前的平均評級為 “適度買入”。最近的內部交易顯示，首席執行官 Vivek Jain 和副總裁 Daniel Woolson 出售了股份，減少了他們的持股。對沖基金持有該股票的 96.10%，顯示出強烈的機構興趣</p>

<p>ICU Medical (NASDAQ:ICUI - Get Free Report) was upgraded by StockNews.com from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note issued to investors on Wednesday.</p>
<div class="lb-trans"><p>ICU 醫療（NASDAQ:ICUI - 獲取免費報告）在週三發佈給投資者的研究報告中，被 StockNews.com 從 “持有” 評級上調至 “買入” 評級。</p>
</div><p>A number of other analysts have also weighed in on the company. Jefferies Financial Group started coverage on ICU Medical in a research note on Monday, October 14th. They issued a &#34;hold&#34; rating and a $183.00 target price on the stock. KeyCorp raised their price objective on ICU Medical from $198.00 to $209.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 13th. Needham &amp; Company LLC reissued a &#34;hold&#34; rating on shares of ICU Medical in a report on Wednesday, November 13th. Finally, Raymond James raised their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an &#34;outperform&#34; rating in a research note on Thursday, September 12th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $173.00.</p>
<div class="lb-trans"><p>其他一些分析師也對該公司發表了看法。傑富瑞金融集團在 10 月 14 日星期一發布的研究報告中開始覆蓋 ICU 醫療。他們對該股票給予了 “持有” 評級，並設定了 183.00 美元的目標價。KeyCorp 在 11 月 13 日的研究報告中將 ICU 醫療的目標價從 198.00 美元上調至 209.00 美元，並給予該公司 “增持” 評級。Needham &amp; Company LLC 在 11 月 13 日的報告中重新發布了對 ICU 醫療股票的 “持有” 評級。最後，Raymond James 在 9 月 12 日的研究報告中將 ICU 醫療的目標價從 158.00 美元上調至 190.00 美元，並給予該股票 “跑贏大盤” 評級。兩位分析師對該股票給予了持有評級，四位分析師則給予了買入評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，平均目標價為 173.00 美元。</p>
</div><p><strong>View Our Latest Report on ICUI</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 ICUI 的最新報告</strong></p>
</div><h2>ICU Medical Stock Performance</h2>
<div class="lb-trans"><h2>ICU 醫療股票表現</h2>
</div><p>NASDAQ:ICUI opened at $169.70 on Wednesday. The stock's fifty day moving average is $176.59 and its 200 day moving average is $144.30. ICU Medical has a fifty-two week low of $82.82 and a fifty-two week high of $196.26. The firm has a market capitalization of $4.15 billion, a PE ratio of -37.13 and a beta of 0.66. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.</p>
<div class="lb-trans"><p>NASDAQ:ICUI 在週三開盤價為 169.70 美元。該股票的 50 日移動平均線為 176.59 美元，200 日移動平均線為 144.30 美元。ICU 醫療的 52 周低點為 82.82 美元，52 周高點為 196.26 美元。該公司的市值為 41.5 億美元，市盈率為-37.13，貝塔值為 0.66。該公司的債務與股本比率為 0.75，速動比率為 1.03，流動比率為 2.29。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In related news, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $18,665,666.78. This represents a 10.29 % decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, VP Daniel Woolson sold 2,502 shares of the company's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total value of $408,376.44. Following the sale, the vice president now directly owns 13,107 shares of the company's stock, valued at approximately $2,139,324.54. This represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 38,502 shares of company stock valued at $6,573,496 in the last three months. 6.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 Vivek Jain 在 10 月 1 日星期二出售了 12,000 股公司的股票。該股票以平均價格 178.46 美元出售，總價值為 2,141,520.00 美元。出售完成後，首席執行官現在直接持有 104,593 股公司的股票，價值為 18,665,666.78 美元。這代表其持股減少了 10.29%。該出售在向證券交易委員會提交的文件中披露，相關文件可通過 SEC 網站獲取。此外，副總裁 Daniel Woolson 在 8 月 30 日星期五出售了 2,502 股公司的股票。該股票以平均價格 163.22 美元出售，總價值為 408,376.44 美元。出售後，副總裁現在直接持有 13,107 股公司的股票，價值約為 2,139,324.54 美元。這代表其持股減少了 16.03%。該出售的披露信息可以在此找到。在過去三個月中，內部人士出售了 38,502 股公司股票，價值為 6,573,496 美元。6.70% 的股票由公司內部人士持有。</p>
</div><h2>Hedge Funds Weigh In On ICU Medical</h2>
<div class="lb-trans"><h2>對 ICU 醫療的對沖基金看法</h2>
</div><p>A number of large investors have recently modified their holdings of ICUI. SG Americas Securities LLC grew its holdings in ICU Medical by 441.7% during the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after buying an additional 4,744 shares during the last quarter. Sei Investments Co. grew its holdings in ICU Medical by 52.1% during the 1st quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier's stock valued at $3,068,000 after buying an additional 9,793 shares during the last quarter. Silvercrest Asset Management Group LLC grew its holdings in ICU Medical by 109.4% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier's stock valued at $29,882,000 after buying an additional 145,485 shares during the last quarter. Vanguard Group Inc. grew its holdings in ICU Medical by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier's stock valued at $263,226,000 after buying an additional 11,991 shares during the last quarter. Finally, Savant Capital LLC acquired a new stake in ICU Medical during the 2nd quarter valued at $431,000. 96.10% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投資者最近調整了他們對 ICU 醫療的持股。SG Americas Securities LLC 在第二季度將其在 ICU 醫療的持股增加了 441.7%。SG Americas Securities LLC 現在持有 5,818 股醫療器械供應商的股票，價值為 691,000 美元，此前在上個季度又購買了 4,744 股。Sei Investments Co.在第一季度將其在 ICU 醫療的持股增加了 52.1%。Sei Investments Co.現在持有 28,586 股醫療器械供應商的股票，價值為 3,068,000 美元，此前在上個季度又購買了 9,793 股。Silvercrest 資產管理集團在第一季度將其在 ICU 醫療的持股增加了 109.4%。Silvercrest 資產管理集團現在持有 278,436 股醫療器械供應商的股票，價值為 29,882,000 美元，此前在上個季度又購買了 145,485 股。先鋒集團在第一季度將其在 ICU 醫療的持股增加了 0.5%。先鋒集團現在持有 2,452,720 股醫療器械供應商的股票，價值為 263,226,000 美元，此前在上個季度又購買了 11,991 股。最後，Savant Capital LLC 在第二季度收購了 ICU 醫療的新股份，價值為 431,000 美元。96.10% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>About ICU Medical</h2>
<div class="lb-trans"><h2>關於 ICU 醫療</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU 醫療公司及其子公司開發、製造和銷售用於輸液治療、血管通路和生命監護應用的醫療設備。其輸液治療產品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的無針產品；Neutron 導管通暢設備；ChemoClave 和 ChemoLock 封閉系統轉移設備，用於限制有害藥物或蒸汽濃度的逸出，阻止環境污染物進入系統，並消除針刺傷害的風險；Tego 無針連接器；Deltec GRIPPER 非穿刺針用於門靜脈通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than ICU Medical</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>Super Micro Computer Soars 28%: Is It Really Out of the Woods?</li>
<li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness</li>
<li>Traders Are Flocking Back to Oil: What’s Fueling the Optimism</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>3 Hot Stock Trends to Ride Into 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 ICU 醫療</li>
<li>股息篩選器：如何在購買前評估股息股票</li>
<li>超級微型計算機飆升 28%：它真的走出困境了嗎？</li>
<li>股息之王寶潔在財報後疲軟時值得買入</li>
<li>交易者紛紛迴歸石油：是什麼推動了樂觀情緒</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>3 個熱門股票趨勢，助力 2025 年</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNVSQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ICUI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><p>→ Even Trump can’t stop what’s coming. (From Behind the Markets)(Ad)</p>
<div class="lb-trans"><p>→ 即使特朗普也無法阻止即將發生的事情。（來自市場背後）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDQ4NA" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10484&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in ICU Medical right now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 ICU 醫療嗎？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 ICU 醫療之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 ICU 醫療並不在名單上。</p>
</div><p>While ICU Medical currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 ICU 醫療目前在分析師中獲得了 “適度買入” 的評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

ICU 醫療（納斯達克股票代碼：ICUI）在 StockNews.com 被升級為買入評級